Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab [Phase 2]
This clinical trial update describes a Phase 2 study evaluating molecular changes in adults with moderate-to-severe hidradenitis suppurativa…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry Skin
This completed observational study collected real-world user feedback on DIPROBASE Advanced Eczema Cream for adults and children with eczema…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND [Phase 3]
Long-term extension study (ECZTEND) of tralokinumab in adults with Atopic Dermatitis who previously participated in tralokinumab trials; the…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Tralokinumab for Dupilumab Failures [Phase 4]
Phase 4 clinical trial update evaluating tralokinumab for patients with atopic dermatitis who failed dupilumab; the study is active but not …
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical study evaluating AK120 in adolescents with moderate-to-severe Atopic Dermatitis is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
This update reports results from an open-label extension study of upadacitinib in adults with moderate-to-severe atopic dermatitis, with the…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients [Phase 1, Phase 2]
This clinical trial update notes that MG-K10 is being studied in adolescents with moderately severe atopic dermatitis in a Phase 1/Phase 2 p…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Herbal Compound for Eczema [Phase 2]
Phase 2 clinical trial of a herbal compound for eczema and atopic dermatitis is active but not recruiting. Sponsored by Fasa University of M…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis. [NA]
Clinical trial update indicating ongoing recruitment for a dermocosmetic product evaluating efficacy and skin tolerability in subjects with …
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD) [Phase 2]
A Phase 2 clinical trial of AK120 in adolescents with moderate-to-severe Atopic Dermatitis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 study evaluating ASN008 for anti-pruritic effects in adults with mild to moderate atopic dermatitis completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update on B244 Topical Spray for pruritus in adults with a history of atopic dermatitis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis [NA]
A completed clinical trial evaluated a probiotic food supplement containing Bifidobacterium infantis EVC001 in healthy breastfed infants at …
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Mother-Infant Cohort Study in Malaysia and China
This is a mother-infant cohort study in Malaysia and China examining gut microbiota and related gastrointestinal symptoms, with outcomes inc…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of VC005 in healthy subjects and patients with mild to moderate atop…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: The Incidence of Venous Thromboembolism in Atopic Dermatitis
This clinical trial update reports completed results on the incidence of venous thromboembolism in individuals with atopic dermatitis, with …
-
FDA approval · 2024-12-09FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approval of Hikma's generic Triamcinolone Acetonide (ANDA 215254) as an original-application topical corticosteroid product for dermatol…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis [NA]
This clinical trial update reports the completed evaluation of the efficacy of TOPIALYSE Baume Protect+ for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluated whether nemolizumab affects cytochrome P450–mediated drug metabolism in adults with moderate-to-severe atopic derm…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Effects of Abrocitinib Treatment on Skin Barrier Function
This clinical trial evaluates the effects of abrocitinib on skin barrier function in individuals with atopic dermatitis. The study is curren…
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis [Phase 2]
An open-label Phase 2 pilot trial evaluating oral ivermectin for atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of AK120 in adults with moderate to severe atopic dermatitis has completed.
-
FDA approval · 2024-11-25FDA Approved: HYDROCORTISONE — Original Application (Eywa Pharma Inc)
FDA approved HYDROCORTISONE from Eywa Pharma Inc under an Original Application (ANDA 217160). This entry documents the approval of a generic…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Study of TAVO101 in Atopic Dermatitis Patients [Phase 2]
Phase 2 clinical trial evaluating TAVO101 for atopic dermatitis is active but not recruiting. Sponsor: Tavotek Biotherapeutics.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
A completed observational study in Chinese participants with atopic dermatitis evaluating how patients are treated with upadacitinib, includ…